Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.65 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.51 |
| ▸ | CHRNA1 | P02708 | 1/20 | 0.51 |
| ▸ | CHRNG | P07510 | 1/20 | 0.51 |
| ▸ | CHRNB1 | P11230 | 1/20 | 0.51 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.51 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.51 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.51 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.51 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.51 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.51 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.51 |
| ▸ | CHRND | Q07001 | 1/20 | 0.51 |
| ▸ | TTR | P02766 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29619400 | 1.00 | TSHR (0.65) | TSHRHPGDSRD5A2SMN1; SMN2CHRNA1 | |
| Hydrochloric Acid SCHEMBL14660193 | 0.98 | TSHR (0.63) | TSHRHPGDSRD5A2SMN1; SMN2CHRNA1 | |
| SCHEMBL2924706 | 0.84 | HPGD (0.54) | TSHRHPGDSRD5A2SMN1; SMN2CHRNA1 | |
| Terephthalic Acid SCHEMBL27403238 | 0.83 | CYP3A4 (0.68) | TSHRHPGDSRD5A2SMN1; SMN2ALDH1A1 | |
| SCHEMBL4546533 | 0.83 | HPGD (0.53) | TSHRHPGDSMN1; SMN2CHRNA1CHRNG | |
| SCHEMBL703716 | 0.83 | HPGD (0.53) | HPGDSMN1; SMN2CHRNA1CHRNGCHRNB1 | |
| SCHEMBL703101 | 0.83 | TSHR (0.65) | TSHRSRD5A2SMN1; SMN2ALDH1A1MEN1 | |
| Methylpiperazine SCHEMBL27675357 | 0.82 | HPGD (0.47) | TSHRHPGDSMN1; SMN2SLC6A2SLC6A4 | |
| SCHEMBL10778405 | 0.81 | HPGD (0.51) | TSHRHPGDSMN1; SMN2CHRNA1CHRNG | |
| Hydrogen Sulfide SCHEMBL28759691 | 0.81 | TSHR (0.63) | TSHRSRD5A2SMN1; SMN2ALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 514 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109212056-B | Gas chromatography-mass spectrometry combined method for determining three trace monohalogenated methylbenzoic acids in water source water | 丁立平 | 2021-05-07 | — | — | CN | claimed |
| EP-3551633-B1 | SUBSTITUTED PYRAZOLOAZEPIN-4-ONES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS | LEO PHARMA AS (DK) | 2021-03-31 | — | — | EP | claimed |
| CN-108218708-B | Preparation method and application of 5-chloro-4-methyl-2-nitrobenzoic acid | 利尔化学股份有限公司 | 2021-01-05 | — | — | CN | claimed |
| EP-3551633-A1 | SUBSTITUTED PYRAZOLOAZEPIN-4-ONES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS | Leo Pharma A/S (DK) | 2019-10-16 | — | — | EP | claimed |
| WO-2018108230-A1 | SUBSTITUTED PYRAZOLOAZEPIN-4-ONES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS | LEO PHARMA A/S (DK) | 2018-06-21 | — | — | WO | claimed |
| EP-1797186-B1 | EXPRESSION SYSTEM, COMPONENTS THEREOF AND METHODS OF USE | NAT RES COUNCIL CANADA (CA) | 2016-05-25 | — | — | EP | claimed |
| US-8728759-B2 | Reverse cumate repressor mutant | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2014-05-20 | — | — | US | claimed |
| US-8252556-B2 | Reverse cumate repressor mutant | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2012-08-28 | — | — | US | claimed |
| US-20110171686-A1 | REVERSE CUMATE REPRESSOR MUTANT | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2011-07-14 | — | — | US | claimed |
| US-20090176275-A1 | EXPRESSION SYSTEM, COMPONENTS THEREOF AND METHODS OF USE | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2009-07-09 | — | — | US | claimed |
| US-20080311618-A1 | Expression System, Components Thereof and Methods of Use | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2008-12-18 | — | — | US | claimed |
| EP-1797186-A4 | EXPRESSION SYSTEM, COMPONENTS THEREOF AND METHODS OF USE | CA NAT RESEARCH COUNCIL (CA) | 2008-11-12 | — | — | EP | claimed |
| EP-1797186-A1 | EXPRESSION SYSTEM, COMPONENTS THEREOF AND METHODS OF USE | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2007-06-20 | — | — | EP | claimed |
| WO-2006037215-A1 | EXPRESSION SYSTEM, COMPONENTS THEREOF AND METHODS OF USE | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2006-04-13 | — | — | WO | claimed |
| US-20040205834-A1 | System for inducible expression in eukaryotic cells | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2004-10-14 | — | — | US | claimed |
| EP-1385946-A2 | A SYSTEM FOR INDUCIBLE EXPRESSION IN EUKARYOTIC CELLS | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2004-02-04 | — | — | EP | claimed |
| WO-2002088346-A2 | A SYSTEM FOR INDUCIBLE EXPRESSION IN EUKARYOTIC CELLS | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2002-11-07 | — | — | WO | claimed |
| US-12466816-B2 | Fused cyclic compound capable of degrading protein and use thereof | SHANGHAITECH UNIVERSITY (CN) | 2025-11-11 | — | — | US | disclosed |
| US-3982931-A | N,N-di-sec.butyl-benzamide herbicides | MONTEDISON S.P.A. (IT) | 1976-09-28 | — | — | US | disclosed |
| US-3952012-A | MULTISTAGE | MCNEIL LABORATORIES, INCORPORATED (US) | 1976-04-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12466816-B2 | Fused cyclic compound capable of degrading protein and use thereof | PSMD7, PSMD2, PSMA6 | TSHR 4431/4885HPGD 1578/4885SRD5A2 2049/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.